Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
w^nlant ®nibers^itp
3autiolpI) iRata£( iHebical Hihravp
^ i^
Digitized by the Internet Archive
in 2010 with funding from
Lyrasis IVIembers and Sloan Foundation
http://www.archive.org/details/twaveyearbook2007edit
TULANE UNIVERSITY
SCHOOL OF MEDICINE
CLASS OF 2007
T-WAVE
VOLUME XXI
NEW ORLEANS, LOUISIANAmmmmmmmae'.
Tulane Universily
3^
S^i
Sf^eOfh
^
^ ^2
ITulane University
Tulane University Medical CenterSCHOOL OF MEDICINEOffice of Admissions SL671430 Tulane AvenueNew Orleans, Louisiana 70112-2699
(504) 588-5187 Fax: (504) 988-6735
October 30, 2002
Dear Class of 2007,
I take great pleasure in informing you of your appointment to the fixst-year medical class at the
Tulane University School of Medicine, to enter in August of, 2003. 1 sincerely hope that you will
accept our invitation to take your medical training at Tulane and look forward to having youjoin us.
In order to reserve your place in the class, we must receive, within the next two weeks, written
notification ofyour intent to accept our invitation. At anytime between now and May 15, 2003, we
must receive a check, payable to the Tulane Educational Fund, in the amount of $500; this deposit
will be credited against your first tuition billing. Please understand this deposit is non-refundable and
should indicate your final decision to attend Tulane University School of Medicine. We ask that
should you decide not to attend Tulane, you inform us in writing so that we can maintain an accurate
accounting of our class.
I am sure you will understand that your appointment is contingent upon successful completion ofthe
academic program in which you are currently enrolled, and maintenance of the level of academic
performance that was part of the basis for your acceptance. A final transcript ofyour grades must be
forwarded to this office as soon as your school year ends.
You will be receiving additional information concerning summer programs, combined-degree
programs, and other topics of interest as the year progresses. I and others at the medical school will
try to keep you well informed of all important or interesting topics.
On behalf of the students, faculty, and administration at Tulane, I bid you a most enthusiastic
welcome. If I can be of service to you in any way, please feel free to call upon me.
Sincerely yours.
Joseph C. Pisano, Ph.D
Associate Dean
JCP/kj
Tulane University|
3
LP
L
THE OATH OFHIPPOCRATE
I swear by Apollo, the physician^ and Aesculapius, and Health and
All-Heal, and by God and by whatever I hold most sacred? that, ac-
cording to my ability and judgment, I will keep this Oath and this
stipulation—I will look upon those who shall have taught me this
Art even as one ofmy parents. I will share my substance with them,
and I will supply their necessities ifthey be in need. I will regard their
offspring in the same footing as my own brethren, and I will teach
them this Art, if they shall wish to learn it, without fee or covenant.
I will impart a knowleidge of the Art by precept, by lecture and by
every mode of teaching not only to my own children but to the chil-
dren of those who have taught me, and to disciples bound by cove-
nant and oath, according to the Law of Medicine, but to none other.
The regimen I adopt shall be for the benefit of my patients ac-
cording to my ability and Judgment and I will abstain from what-
ever is deleterious and mischievous. I will seek to inform mypatients fully about their illness and prognosis, and will always
remember that the final decision regarding their own life rests
with the patient. I will regard my patients always as fellow hu-
man beings and will do everything possible to preserve their dig-
nity. With purity and with holiness I will pass my life and prac-
tice my Art. Whatsoever things I see or hear concerning the life
of men in my attendance, on the sick or even apart therefrom,
which ought not to be noised abroad, I will keep silence thereon,
counting such things to be sacred secrets. While I continue to
keep this Oath unviolated, may it be granted to me to enjoy life
and the practice of the Art, respected by all men, in all times. But
should I trespass and violate this Oath, may the reverse be my lot.
ITulane University
llv .' 1131
111! (5,
I IK 'i
-.il1'^' .*
1 I I
I i «>, ...
1 - ^!ll! lim llftr
S - II-.
Pfbs?
^:^*«C
Vaf« >**'
K-.®4gB!^^'-''
|'l| Hnn" n n II n n
fel)
\" '#• < Iff '# t
K|r:"r-:^-
::^^i29*!-'
t *
-1«
uianeUNIVERSITYMEDICAL CENTER
Hospital & Clinic !;•% #'S^sijll?*:
Jik
f%
.Kt" r.
^Ai
*MI-4
>• <i3
Tulane University|
5
6I
Tulane University
m^
w*-^^-i
V
NEW ORLEANt sighted as Indian por^.
o Lake Pontchartrain and Gul.:in 1699 by Bienville and Iberville.
p'ounded by Bienville In 1718;
Earned by him In honbr of the
JuRe of Orleans, Regentfpf France. ^Called the Crescent City because of
^location \n bend of the Mississippi. |
II
r
^Szfe'*-*^
-y.
mij??
7r
A\
MTulane University
|/
Tulane University
f^-'^-^;nc.
Tulane University | 9
p ^^^^^^<^9^^^^^^^^^^^^^^^^^^^^H
p^^uH
iP^jwH'ic^r yiPJpBJ^H
rln^a^mSJ».v
^^^^^Tx^Jj^^ fe^^-^F^10
ITulane University
Tulane University|
11
12I
Tulane University
Tulane University|
13
14I
Tulane University
Katrina
Tulane University|
15
16I
Tulane Univefsity
Tulane University|
17
P«^^^H'
'"^'-^rlP'H
¥kki^lmf'4 liil
^^1 Iw^v-^^'^^^^^^Hhv Wf A HP 1
r /1
18I
Tulane University
Tulune University|
19
20I
Tulane University
Cadaver Ball
Tulane University|
21
22I
Tulane University
at Home and
lulane University|23
/^
(^
''jll^^i
24I
Tulane Univer'iity
Tulane University|25
26I
Tulane University
WT —
1
Hi' ^^^^m^^^^^/-"^
, ..^mW A
f ^^H||MHj£^g»<t^^EggM|H|^^H^H|H
Tulane University|27
28I
Tulane University
Tulane University|29
30I
Tulane Univer'^ity
Tulane UnivRrsitvI
31
32I
Tulane University
Tulane University|33
»-J^^H^D^H^^^^^^^^^^^kEiS^^^^r1>#
^**^^>
.
J^WMF ^'T^ 1k^^/Jl
i|Bj|^Hw 1V^ ^^^^^H
w/ \m ^^f ^£mmb— '
34I
Tulone University
Mardi Gra
Tulane University|35
36I
Tulane Unive'"jity
Mardi Gra
Tulane University|37
38I
Tulane Univerity
Tulane University|39
'^.Ji^^j,
-X- « , 1 4
^^n4 .JT^ A i'^'s^il^^ ^>
W^:l^Mni^^^^^^Mf^^- ?l^jEp^T. !
II -^MSi'i n'^*^-
'
!l£^%l fW "^^ '^' iM# 11*- «-^P""*^ T^i1 IS;, wf &
40I
Tulane Univerity
Tulane Universily|
41
42I
Tulane University
Tulane University|43
s
44I
Tulane Universitv
Tulane University | 45
46I
Tulane Universit"
Tulane llniversitvI47
48I
Tulane University
Tulane University|49
^^^^^^^^^^^^^H
BIS^^^^^1
H^fert^^^H [^^
V ^ hM^^m k
r^ ^^H ^^H ^^L
^^L
^^mm- nHift^ftj* * <^^^L
/v ^^^1^H^HL^j,
K-'ar-^> ^'^^ il#n^^H.V flB^ >^
• ^^bL '- '^k. .^Mi^mlMr 3^Kl *« / >
. ^Bk^ ^^»™w Jm WKK. ^^:*.^J1m^ ^ mT'*^*^^^
vS^B
' m^-
^^B!»--
y.^-
•SBTK J
50I
Tulane Universi'y
Tulane University|
51
52I
Tulane University
Tulane University|53
54I
Tulane University
Tulane University|55
ut and About
56I
Tulane University
^^^^^^^Pl^JM^^H^K-^N^^^^L r?i
ll<
\
1 ^MLki^feK.' "^Sl^^v^^m
aJUOJJUaWjgaU^AJLU-LLMJ
Tulane University|57
CHAD ABBOTTFamily Medicine
U Washington Affil. Hosp.
Seattle. WA
MICHAELABDULIANOrthopaedic Surgery
Case Western Univ Hosp.
Cleveland, OH
STEPHEN AGANSEmergency Medicine
LSU SOMNew Orleans, LA
ZEENAAL-DUJAILIMedicine - Prelim
Ochsner Clinic Foundation
New Orleans, LADeiTnatology
Tulane University SOMNew Orleans, LA
MATTHEWALLEMANSurgery - Prelim
Univ of North Carolina
Chapel Hill, NC
DUDLEY ATKINSONSurgery - Prelim
Ochsner Clinic Foundation
New Orleans, LAUrology
LSU/OCHSNERNew Orleans, LA
JEAN AUZENNEPsychiatry
Vanderbilt
Univ Med Ctr
Nashville, TN
APRIL BAILEYRadiology - Diagnostic
U Texas^SW Med Sch
Dallas, TX
JUSTIN BARKERSurgery - Prelim
Univ of Colorado
Denver, CO
JULIA BARNETTSurgery - Prelim
U Washington Affil. Hosp.
Seattle, WA
OSCAR BATLLEMedicine - Prelim
Univ of Missouri
Kansas City, MOOpthalmology
Univ of Missouri
Kansas City, MO
ANDREA BECKInternal Medicine
Tulane Univ SOMNew Orleans, LA
ROBERT BECKInternal Medicine
Tulane Univ SOMNew Orleans, LA
WILLIAM BECKGeneral Surgery
Vanderbilt Univ Med Ctr
Nashville, TN
CAREN BECKERGeneral Surgery
Ochsner Clinic Foundation
New Orleans, LA
OREN BERNSTEINAnesthesiology
UCLA Medical Center
Los Angeles, CA
JENNIFER BERUMENGeneral Surgery
UC San Diego Med Center
San Diego, CA
JUNAID BHUTTOInternal Medicine
Tulane Univ SOMNew Orleans, LA
LAUREN BLEICHInternal Medicine
Lahey Clinic
Burlington, MA
ELIZABETH BORSHARDOtolaryngology
West Virginia Univ SOMMorgantown, WV
DAVID BOWDENInternal Medicine
CA Pacific Med Center
San Francisco, CA
REGINA BOWEMedicine-Pediatrics
Tulane Univ SOMNew Orleans, LA
ASH BOWENUrology
Tulane Univ SOMNew Orleans, LA
ASHLEY BROUSSARDMedicine - Prelim
U Texas Med School
Houston. TXAnesthesiology
George Washington UWashington, DC
JEFFREY BURFORDGeneral Surgery
Univ Arkanas
Little Rock, AR
JOHN CAMPAGNAPediatrics
Tripler AMCHonolulu, HI
MARK CAVANAUGHPrelim Surgery
Univ. Michigan
Ann Arbor. MI
HELEN CAVASINOB/GYNU. Arizona Affil. Hosp.
Tucson, AZ
SETH COHENSurgery - Prelim
Lenox Hill Hospital
New York, NYUrology
Lenox Hill Hospital
New York. NY
CRAIG CONARDPediatrics
OSU/Children's Hosp.
Columbus, OH
MANDY CRAUSEMedicine-Prelim
Ochsner Clinic Foundation
New Orleans, LARadiology- Diagnostic
Tulane Univ SOMNew Orleans, LA
JASMEEN DARAPediatrics
St. Christopher's Hospital
Philadelphia, PA
BENNETT DAVISFamily Medicine
Camp Pendleton
C. Pendleton, CA
CRAIG DENLINGEROrthopaedic Surgery
Univ Tennessee COMMemphis, TN
KAPILDHINGRAEmergency Medicine
UC Davis Med Center
Sacramento, CA
RENEE DOLLAnesthesiology
Albany Med Center
Albany, NY
MEENAKSHI DUTTAPediatrics
Tulane Univ SOMNew Orleans, LA
ISSAM EIDOtolaryngology
Univ Texas HSCSan Antonio, TX
GUSTAVO FABREGAAnesthesiology
Univ Arkansas
Little Rock, AR
MIGUEL FABREGAMedicine-Prelim
LSU SOMNew Orleans, LARadiology-Diagnostic
Univ Texas Med School
Houston, TX
ADILFATAKIAOtolaryngology
Tulane Univ SOMNew Orleans, LA
MICHELLE FERNANDEZEmergency Medicine
NY Hosp/Medical Center
Flushing, NY
JOSHUA FOWLERMedicine-Prelim
Tulane Univ SOMNew Orleans, LA
AMY FOXMedicine - Prelim
U. N. Carolina Hosp.
Chapel Hill, NCDennatology
U. N. Carolina Hosp.
Chapel Hill, NC
JONATHAN FRIEDMANTransitional
Colorado Health Foundation
Radiology - Diagnostic
U. Texas SW Med School
Dallas, TX
AARON FRITTSInternal Medicine
Temple Univ Hospital
Philadelphia, PA
THOMAS GALLENAnesthesiology
Med. Coll. Of Georgia
Augusta, GA
58I
Tulane University
HUGH GILLSurgen -Prelim
Georgetown Univ
Washington. DCNeurosurgery
Georgetown Univ
Washington, DC
LL\T GOLDMANMedicine - PrehmLSU SOMNew Orleans. LAPhysical Med. & Rehab.
Temple Univ Hosp.
Philadelphia. PA
DALLIS GREENGeneral Surger)'
Naval Med Center
Portsmouth. VA
MORGAN HAILEMedicine - Prelim
Tulane Univ SOMNew Orleans. LARadiology-Diagnostic
Tulane Univ SOMNew Orleans. LA
NATALL^ HANNANSurger\' Post. Doc. Research Fellow.
Tulane SOMNew Orleans, LA
.JEFFREY HARRGeneral Surgery
Univ. of Colorado
Denver, CO
STACY HEIMBURGER-Medicine/Neurology
Tulane Univ SOMNew Orleans, LA
.JAY HEINTZUrology
Univ Maryland
Baltimore, MD
JENNIFER HEWSONOB/GYNOregon Health & Science
Portland. OR
MARCO HIDALGOSurgery Post. Doc. Research Fellow.
Tulane SOMNew Orleans. LA
VIVIAN IIOANGPrelim MedTulane
New Orleans. LANeurology
Georgetown Univ Hosp.
Washington, DC
ABIGAIL HOFFMANGeneral Surgery
Methodist Hospital
Houston. TX
LARKIN HOLTFamily Practice
Ventura Co. Med. Cent.
Ventura, CA
KRISTINA JOHANSENOB/GYNSAUSHECLackland AFB, TX
KRISTEN JONESSurgery - Prelim
U. Pittsburgh Med Cent.
Pittsburgh, PANeurosurgery
U. Pittsburgh Med Cent.
Pittsburgh. PA
MAYA JONESPediatrics
U. of Southern CALos Angeles, CA
ROBERT JUNGMANInternal Medicine
Boston Univ Med. Cent
Boston, MA
GEETA KARNIKInternal Medicine
Georgetown Univ. Hosp.
Washington, DC
KIRAN KAURInternal Medicine
Univ Texas Med. School
Houston, TX
JOHN KIMTransitional
Emory Univ SOMAtlanta, GAOphthalmology
Emory Univ SOMAtlanta, GA
BRENNAKLOVNINGEmergency Medicine
Maricopa Med. Center
Phoenix, AZ
STEPHANIE KNIGHTPsychiatry
U. of Maryland Med Cent.
Baltimore, MD
SARAH KOENIGFamily Practice
Group Health Coop
Seattle, WA
SPENCER KRANERobotic Urologic Research Fellow.
Henry Ford Med. Cent.
Detroit. MI
MATTHEW LADRAMedicine - Prelim
St. Mary's Med. Cent.
Long Beach, CARadiation Oncology
U. Washington Affil. Hosp.
Seattle. WA
JUSTIN LAFRENIEREInternal Medicine
Naval Med Ctr
Portsmouth, VA
NICOLE LAZARCIUCEmergency Medicine
Hosp. of U. Pennsylvania
Philadelphia, PA
LIFT LEMedicine - Prelim
Tulane Univ SOMNew Orleans, LADermatology
Tulane Univ SOMNew Orleans, LA
THU-BA LEBAOrthopaedic Surgery
U. Texas Med. Branch
Galveston, TX
CALVIN LEEInternal Medicine
Mass. General Hosp.
Boston, MA
TRAVIS LEEMedicine - Prelim
Tulane Univ. SOMNew Orleans, LAAnesthesiology
Jackson Memorial Hosp
Miami, FL
KRISTINA LEWISMedicine - Primary
Mass. General Hosp.
Boston, MA
DOUGLAS LINCOLNPediatrics
Oregon Health & Science
Portland. OR
MIKE LINDSEYSurgery - Prelim
Univ. Vermont
Burlington. VT
MAUD LIVAOB/GYNUniv Tennessee COMMemphis, TN
STEVEN LUDWINMedicine - Prelim
Thomas Jefferson Univ
Philadelphia, PAPhysical Med. & Rehab
Thomas Jefferson Univ
Phildelphia, PA
STEPHANIE MALLIARISGeneral Surgery
Weill Cornell Medical Cent.
New York, NY
DANIEL MANTUANIEmergency Medicine
Alalmeda Co. Med Cent.
Oakland, CA
ERICA MARINPediatrics - Primary
Children's National Med Ctr.
Washington, DC
SARAH MARKLEYPediatrics
Stanford Univ. Progs.
Palo Alto, CA
ALEX MATTHEWSFamily Practice
St. Francis Hospital
Memphis. TN
CHRIS MAYORGAInternal Medicine
U. Chicago Med. Cent.
Chicago, IL
JESSICA MCDONALD-TOPMedicine/Pediatrics
Tulane Univ. SOMNew Orleans, LA
LYNN MODELGeneral Surgery
Yale/New Haven Hosp.
New Haven, CT
AIMEE MONTEROInternal Medicine
Tulane Univ SOMNew Orleans, LA
DEEPA MOI'ARTYInternal Medicine
Methodist Health System
Dallas, TX
Tulane University|59
BEN MOSESSurgery - General
SAUSHEC
-
Brooke Army Med. Center
Urology
U. of Texas Health Sciences
San Antonio, TX
ETHAN MOSESTransitional
St. Anthony's Hospital
Oklahoma City, OK
AYE MYINT-UPsychiatry
Brown Univ
Providence. RI
BIBA NIJJAROB/GYNBoston Univ Med Cent.
Boston, MA
CHRIS OBRIENTransitional
U. of Tennessee Grad. SOMKnoxville, TNOphthalmology
LSU/OchsnerNew Orleans, LA
EVE OSTERPediatric - Primary
Mt. Sinai Hospital
New York, NY
LEENA PANDESurgery - Prelim
Mt. Sinai Hospital
Chicago, IL
Radiology-Diagnostic
Cook Co. Stroger Hosp.
Chicago, IL
SZEKIM PANGFamily Practice
St. Francis Hospital
Memphis, TN
MATTHEW PATTERSONMedicine - Prelim
Emory Univ SOMAtlanta, GAAnesthesiology
Emory Univ SOMAtlanta, GA
ROD PELLENBERGPediatrics
Baylor Coll. Of Medicine
Houston, TX
ANTHONY PERRYPathology
St. Joseph's Hospital
Phoenix, AZ
WYNTER PHOENIXGeneral Surgery
U. of Arizona Affil. Hosp.
Tucson, AZ
GAYLE PLETSCHMedicine/Neurology
Tulane Univ SOMNew Orleans, LA
ULANA POGRIBNAPediatrics
U. Texas Med. Cent
Houston, TX
DAVID POPOLIMedicine-Prelim
Boston Med. Cent.
Boston, MAPhysical Med. & Rehab.
Harvard/Spaulding
Boston, MA
NATHAN POULSONAnesthesiology
Hershey Med. Cent.
Hershey, PA
NEEMA POURTAHERIOithopaedic Surgery
St. Joseph's Reg. MedPaterson, NJ
SARAH PRESENTFamily Medicine
Oregon Health & Science
Poitland, OR
LAUREN RABINOB/GYNU. of Maryland Med. Ctr
Baltimore, MD
ERIK REITEFamily Medicine
USAF Regional Hosp.
EglinAFB,FL
KELLY RENNIESurgery Post. Doc. Research Fellow.
Tulane Univ SOMNew Orleans, LA
ADAM RIVESOrthopaedic Surgery
Univ of Missouri
Kansas City, MO
TANYA ROGOPediatrics
INOVA/Fairfax Hospital
Falls Church, VA
ROBIN ROLANDEmergency Medicine
Washington Hosp. Center
Washington, DC
ACHAL SAHAIInternal Medicine
Baylor College of Medicine
Houston, TX
GOPI SHAHOtolaryngology
Thomas Jefferson Univ
Philadelphia. PA
MARGARET SOULENPediatrics
Wright St. U. Boonshoft SOMDayton, OH
REBECCA STACKHOUSEMedicine-Prelim
Norwalk Hospital
Norwalk, CTRadiology-Diagnostic
Yale/New Haven Hosp.
New Haven, CT
JEFFREY STIMACOrthopaedic Surgery
U. of Louisville SOMLouisville, KY
LUISA TODDEmergency Medicine
U. of Utah Affil Hosp.
Salt Lake City, UT
JENNIFER TORPPediatrics
Tulane Univ SOMNew Orleans, LA
LANDON TROSTSurgery-Prelim
Mayo Sch. of Grad. Education
Rochester, MNUrology
Mayo Sch. of Grad. Education
Rochester, MN
MICHAEL TUBIANOSAFamily Medicine
Univ. of Hawaii
Mililani, HI
HARMEETH UPPALSurgery - Prelim
Harbor/UCLA Med Center
Torrance, CA
ADAM VAN DEN BOOMPediatrics
Naval Medical Center
Portsmouth, VA
ROSALBA VARGASPediatrics
Baylor College of Medicine
Houston, TX
SHANNON WAGNERPsychiatry
Northwestem/McGaw
Chicago, IL
JARED WAKEMANPsychiatry
George Washington U.
Washington, DC
KATHRYN WATTSRadiology-Diagnostic
Ochsner Clinic Found.
New Orleans, LA
SACHA JUNIUS WAXOB/GynOchsner Clinic Foundation
New Orleans, LA
MEGAN WESTBROOKPediatrics
Baylor College of Medicine
Houston, TX
LUKE WILKINSMedicine-Prelim
Case Western Univ. Hosp.
Cleveland, OHRadiology-Diagnostic
Case Western Univ. Hosp.
Cleveland, OH
AARON WILSONPsychiatry
Tulane Univ. SOMNew Orleans, LA
JEFFREY WOLTERSSurgery-Prelim/Urology
Virginia Commonwealth
Richmond, VA
DANIEL WOMACGeneral Surgery
Med. Center S. Carolina
Charleston, SC
AMY YANGInternal Medicine
Brown Univ Med. Res.
Providence, RI
BRIAN YOUNGPediatrics
Tulane Univ SOMNew Orleans, LA
60 1Tulane University
Zeena Al-Dujaili Dudley Atkinson April Bailey Oscar R. Batlle III Elizabeth Borshard Mandy Crause
Craig Denlinger Issam Eid Jonathan Friedman Aaron Fritts Morgan Haile Jeffrey Harr
Jay Heintz Jennifer Hewson Kristen Jones Douglas Lincoln Mike Lindsey Steph Malliaris
John Kim
Calvin Lee
Dan Mantuani
Erica Marin Sarah Markley Erik Martin Reite Landon Irosl
Tulane University|
61
vrmMiiL^
L. Lee Hamm, M.D.Interim Dean
Mark Kahn, M.D.Associate Dean for Admissions and Student Affairs
Ernest Sneed, M.D.Assistant Dean for Student Affairs
N. Kevin Krane, M.D., FACPVice Dean for Academic Affairs
Barbara Beckman, Ph.D.Assistant Dean for Admissions
Rondel Frank, M.A.Registrar
62I
Tulane University
k iJVBi^HyiP!9 «?-:•-•,. -I^I^W^^^^^.'^^. »*«5a|
Karen Joia Kim Melerine
Melissa Riley Susanna Vargas
Irene Melerine Donald Owens, Ph.D Betty Burton
Tulane University|63
Tulane University
Tulane University|65
ciences
Internal Medicine
66I
Tulane University
Psychiatry & Neurology
Tulane University|67
Tulane University
Tulane University|
69
70I
Tulane University'
A^ . J^>«: ii.Tfiftn
^1?#0.
^j^zM
Tulane University|
71
72I
Tulane Universit"
Tulane University|
73
Oscar BatUeSanto DomingOj
)iiimican Republic
IR^^mB
74I
Tulane University
^am. ^^ni^l
HT L
Tulane University|75
^^^m * -Jw^^ W^^WliL/^^^wK.'
'
^^^^^1
76I
Tulane University
Tulane University|
77
78I
Tulane University
Tulane University|
79
80I
Tulane Univorsily
Tulane University|
81
82I
Tulane University
Tulane University|83
Jolin CampagnaDavenportj lA
Tulane University
Tulane University|85
86I
Tulane University
PIi^^-1i
^^Hg,iJHj-^
1 1 ,^^^^^H||I|1e;'4QS|^B^H
Tulone University|
87
88I
Tulane University
i
Tulane University|
89
90I
Tulane University
Tulane University|
91
92I
Tulane University
Tulone University|93
t^fHfxI 1
Hklf ^^,.H^*,^Tp-'^
\^^^gi^i^^
1 ^^JP3n94
ITulane Utiiver?'ty
jj^^^^^^^^^Hv^^ i l^H
' 1-mI'i.J^^^^Kv. -^^. V^W'^^BBH9|Fvi
^^flj^^ "• M
Tulane University|
95
96I
Tulone Univrrsity
Tulane University|
97
m^MMT^M^fM^^^^ _jW-7W ^^H
^^^K^ ^v ^^^r
•^jfc
i^^^r^^ ^ii|H|
A\mi P ^wr _
mmmm ^'f i^^l
98I
Tulane University
Tulane University|
99
100 1 Tulane University
Tulane University1101
102 1 Tulane University
1wBS^^^'
1
Tulane University1103
B^K^'3|^1 u\ v^ f
wy1 w^
I
104 1 Tulane University
Tulane University1105
1061 Tulane University
Tulane University1107
/.« ><
lllM ' mf -^^^^K A^^Hflw^^^HM
^/iMlnTNS^H"" " ^' m
'A108 1 Tulane University
Pittsburgli
Tulane University1109
110I
Tulane University
Tulane University|111
^"^sn
112I
Tulane University
Tulane University1113
114I
Tulane University
Tulune University|115
^g^^^
116I
Tulane Univprsity
Tulane University|117
118I
Tulane Univfirsity
Tulane University|119
^^HJB|^p^f! fit•mmmi^^^m- ^^^^^^^B''^^imHHi^rzk ^^M
;i
120 1 Tulane University
Tulane University1121
122 1 Tulane University
Tulane University1123
124I
Tulane University
Tulane University1125
I
^^^H ^^^Bkv^ '-^'* "^ --.'-Afc'xAjJ
^^^^^H^^^ ^Hr\-:i:>^-r^^l^^^^^^^^^s ^^^Km->^- :'i- ^^^^1
wmz' '
K-jJl^^j[ "~ °^^^i^^^^B Wk -^^uM^BIim 'JH
H u126 1 Tulane University
Tulane University1127
'S'J^^'^TS'm"~^ ^y '
128I
Tulane University
Tulane University |129
130I
Tulane UnWersity
Tulane University1131
132 1 Tulane University
Tulane University1133
134 1 Tulane University
Tulone University1135
^B^I^^B^^I 1 "'^' rVv^l ^^^^^1WS^^^^^M ^^^•M" i^fP^^I^^H^H
H^^l ^^H^^^^p ^^^
,,
.
ji "1^ ^^^Vyv;
^^^^^^kk HH^^
136 1 Tulane University
Tulane University1137
^^E H^^
'
B~X'':* tf '^D
w/IP / 9'
Hk^^^^H U_^^- .^^
¥'.' "^^^^^^1I^^^Su.
T^/ ^-i^.f^^^1^^^138 1 Tulane University
IJWV^^^^B
^cfl
^^p fH^^^^^^^^^^^^^^^^^^^^I
r i,^^iH^pm
L
V^^^^l
^^/- i/vHB^I
^k ^ iwH
Tulane University1139
140 1 Tulane Univ"rsity
Tulane University1141
142 1 Tulane University
Tulane University1143
New Orleans...there's no place I would've rather done it!
Jay- What can I say brother...4 years of friendship much appreciated. Congratulations on AOA, UMD-urology (keep your eye on
the...), and meeting your lovely wife. You did well during these four years! Never forget though, no matter what, I'll always be taller (I
don't care what your driver's license says), younger (by a year), and while we're at it more handsome. You owe me $50 for Bonds...I'll
take It out of the wedding gift. I will see you and Eva soon. Megalo- You'll always be very special to me. I wish you the best in all
your pursuits and know you will find happiness. ..Your kind-heartedness (which is only rivaled by your lack of knowledge of the world-
What language do we speak in India? In fact, where is India?) assures you of it. Also, you're a hippie, I think you look good in earrings,
and it's about time you bought a big purse. I love you very much. Kev- Who's the biggest guy in the med school? Pound for pound you
know the truth, I missed you third year, but I guess if you were around all we would've done is drink protein shakes, eat Roly Poly, and
talk about your girl troubles. Thanks for everything man. AY, AY- I'm glad we were able to spend these last four years building on
what has to my delight turned into a lifelong friendship. I'm sorry about the Chinese food, but I wonder ''are you not entertained?" Oh
and "guys if I wasn't, like, her sister I would totally..." Ap- Lab partners to great friends. It's like destiny. Houston was the best,
once you got rid of that ball and chain. Who else can I daydream about being filthy rich with while lying in the sun, poolside. "So away
from my window..." And don't worry, I was only joking when I said getting dogs cuts your dating pool in half. See you somewhere in the
sun. My girls+l...I couldn't have asked for better roommates. Jess- I think you are one of the sweetest and kindest souls I have ever
met, who can also cook with the best of them. Please try to hold your vodka down and keep the dogs in the front of the house like you
promised! Nate- You're not in school with us, but how can I leave you out. You want to walk up the off ramp to meet Jess in the
middle of the highway? I don't get it, smoke dawg. I know that you and Jess are going to be great together and I look forward to
visiting you guys over the years. Kothryn- "I don't know what it is, but I want it." I love listening to you speak. I'm so glad that you
came back to us. Cool to chill out with, cool to go out with, and cool to spend New Year's with. You've got it all. Morco- We had great
times V year, .then you got married, had a kid, moved to Metairie all in the blink of an eye and I never sow you again. Just joking, I
look forward to always keeping in touch and I wish yourself, Barrie, and Riley (the cutest kid I know) all the happiness in the world.
You'll be good in whatever you chose to do. And Bam'e- Thanks for your friendship. You'll always be a southern belle with social
standing in my eyes. Art- It was good to know you buddy. Wake boarding, Centreville, making you cry on the golf course, tennis court,
and racket-ball court. I enjoyed it all. If anybody did medical school the right way, it was you. FPlttS- One of my favorite memories
remains playing pool, eating a cheeseburger, and having a beer at Igor's. You're a great person, which is maybe why you're so terrible at
talking trash. I'm always there for you. Sopi...come on be honest-who talks more? I wish you guys the best of luck together. MJ-Who's got a chip on their shoulder? Thanks for taking care of me when I was sick 1^^ year and for everything since! It's too bad you
moved to the AAarigny...You like my jokes, come on! Roddy- I'll never bet with you again, but I love you never the less. My mom is still
worried that you're going into pediatrics. I know you'll do great though. So Hoyas! Nicole- Your charm is in your cynicism...but don't
forget that you're destiny is a happy one. Thanks for picking me up on St. Charles at 6am. Zeena- You're not high maintenance. I
loved all the time we spent together V^ year and you get a standing happy birthday from me on Feb 23'"'^ of every year.
Lauren/Liat/Seeta- I only lump you guys together b/c you're such good friends, yet I had separate friendships with each of you
and appreciated each one of them. Thanks. Pinner- Hey man, you made my third year of medical school easy. Lab A2
Craig, Amy, Aimee,Ap,RJ- Let's just start by asking which lab group was the best in our class? You guys were the beginning of a
great experience. Others, all of whom I thank for your friendship-AB,AH,AS,BB,BM,BN,BY,CBx2,CD,CJ,DB,D&,CiM,FaD0,DW,HU,IG,
JBx4,JC,JD,JF,JG,JWx2,DrJW,KJ,KK,LM,LP,MD,MA,MC,ML,NG,NM,NN,NP,OB,RB,RK,RR,SB,SC,SK,SL,SM,SY,SW,TB,TG,TI,TR,WP.
Dad, Mom, Anuj, Rohan, as well as family and friends from further away- im where i am today
because of all your help. Thank you!
144 1 Tulane University
Tulane University1145
146 1 Tulane University
11
^fkm
Tulane University1147
148 1 Tulane Univ:^rsity
^^ <-"
-„
^
|gggTulane University
1149
Michael TubianosaFarmiiigtoiii, CT
ri^kr'!BM
@hI ^Xv*^^!
^^^mTW^^^t^ m9 '^iT^SV^^v ^H
^Qv^^PW Iho150 1 Tulane University
Tulone University1151
152 1 Tulane Uni'/ersity
^w
1
^^W^ ; R^ ^
r ,\
htlV
Tulane University1153
154 1 Tulane University
Tulane University1155
156 1 Tulane University
Tulane Universily1157
158 1 Tulane University
Tulune University1159
160 1 Tulane University
Stephen Agans Jean AuzenneOpelousas, LA
April Bailey
Wenatchee, WAJulia Barnett
Houston, TXWilliam Beck
Stayton, ORJohn Bernard
Boston, MA
Oren Bernstein
Oahu, HILuisa Berry
Boulder, CODavid BowdenDecatur, GA
Ash Bowen Arthur Caire
Slidell, LACraig Conard
Bennett Davis Kapil Dhingra Renee Doll
Orange Park, FL MiUington, NJ
Meenakshi Dutta
Palo Alto, CAAdil Fatakia Joshua Fowler
Gladstone, OR
Jonathan Friedman
Franklin, LADallis Green
Fayatte, MSRobert Jungman
Kuston, LAKiran Kaur
Houston, TXJohn Kim
Pearl City, Hi
Brenna Klovning
Charlottesville, VA
Scott Bourgeois Natalia I lannan
New Orleans, LA
Tulane University1161
j^i
Spencer Krane
Metairie, LAMatthew Ladra Nicole Lazarciuc
Toronto, Ontario
Liet Le Thu-Ba Leba Calvin Lee
Houston, TX
Kristina Lewis Steven Ludwin Daniel Mantuani Erica Marin
Chapel Hill, NC Randolph, NJ Rochester, MI
"^^pr^^
Alexander Matthews Ethan MosesDenver, CO
Aiidrea Montis Beck Aye Myint-U
New York, NY
^vt^Bi
QiiTstopher O'Brien Szekim Pang Anthony Perry Gayle Pletsch
Baton Rouge, LA
Erik Reite
Denver, COMargaret Soulen
Colombus, OHLuke Wilkins Aaron Wilson Daniel Womac Brian Youiig
Adrian, MI New Orleans, LA San Antonio, TX
162 1 Tulane University
Stacy Heimburger Jennifer Hewson Douglas Lincoln
Stephanie Malliaris Jennifer Torp Shannon Wagner
Tulane University1163
mf Ip ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^
H^are scy 3/'c>ii
Or (Xtr o-i(f SLs£cr
/"
Siaa/ /iei/nmri/e/} /"i/L./j.
CMJra£u£t£i(M^f
L(H^c BecKi/ (Kb 7^v
1l fI
U4i!t -m.erdy lAAiybtiievaJjie. .
.
ut'i far IreyonA aAdiXizuta-
iA:\ jiut cLoTAmrlakt. .
.
iKx^rKceivoMe
ConaraUdcdimvi Dr. HedMJruraer,
wt are p<? i^try f^oud ofyou.
We CoT/eyou.
Unxie, At4Mt Kcnui, MaMsoK,y(n4r
joddAu^vterJacky omA Arthur
XOXO i
^^5^^^^^5^?5^^5^^^^^^^^^^^^^^^^^^^^^^^^^^«^^^^
Con^iatuiationi on, t^out ^iadtiation ^m. ^uiuuii SchooU
LUi. uui/igou. aJl tfu. bi^iit 06 tiou, iLoch t/u, nuu-^oaLb aou. tet^ot
gouztd^ and idte. the, taUntii that Qod^aue,gou, to htlp ot/uii
.
UJt. aii, io fiioud o^t^ou./
Couf,, ^ad,, 9^7001, and ^Uan,
(^reatworh, Stephyl
Wey owe^ Kf- IncredMyiyproud/ ofyaw!
Lovey, Moo-, Ted/, OAnd/lvy
164| Tulane Univtrsity
Con/jrahdcutumA to ovw um Seth omA to tke cUm of2007
We wUk you all ike htst oMd for a, s44Axe9sfid cmA rmmrdum
ccure^tr i4t -medkMie. May tke itadcy of TutLute Medlad Sckaoi
cofvti4iAU to Lwt OK.
Frmt tke Coivefi FoMuhj: EUetK, EiLuft) ^eik omA VUia
Tulone University1165
landijClLL
We Me so p\oud of l/oli and we love you
witli all of out hearts'.
mom, ibad, ^skleu, Jiati, and J)ee
You /yiOi/ GinC-tDi^tit&r- /yieaj^ d^-f^ats^ ^ut you /yju^t fiot £>&
de/sai^J. Xjo -fad, it /yios/ ie. ne-C^SSai-y to £nC-oatit^r
t/is de-feats, So you doj^ /(nouj uj/io you are, c^hat you
<ia^ t'iSe -fi-o/t^, Jioto you dori StU/ c.o/yi& o^ of it.
-Maya Atiae-Iou
Dear Stephanie Rose,
You have encountered more in the past four years than many see in a
Ufetime, and you have not been defeated. You have risen from your
experiences in New Orleans and, through it all, you know who you
are more than ever before. We have always been and continue to be
your proud and loving parents. You are a phenomenal woman!
XOXO, Mom and Dad
A ^
Congratulations
morgan ana Jennl
We ale so incieatbiLj
ploaa oj yoal
Witk all oj oul love,
J-^om goal entile J4ailejamdg
The/ early carving of a/future/
hrcuyW HAr^e^yn/.
Con^atulcutuyn/y ViMviphin/,
we/'re/ yo-proud/ ofyou/!
Love/,
Monvand/Johrx/
166| Tulane Univirsity
Michael,
Uove of m.y life, oucrjoutriA/ey together startecH wheiA. we
were ±S years old. (ia, the last decade we have growiA.
together aiA/d achieved oucr dreai/vts haiA/d aiA.d haiA/d. i
will always be your # i. faiA/ aiA/d will su.pporfc y out Iia/
aiA.y eiA^deavor youc u.iA/dertal^e. ThaiA.teyoi/tfbrlettliA/g
n/te walle this jou.riA.ey fucll ofjoy aiA/d laucghter with
you.. I am. so 'prou.d aiA/d hoiA/ored to have you. as m.y
hu.sbaiA/d. CoiA/gratu.latloiA/s!
You.r best frleiA^d aiA/d wife
L-ove always,
3ylvla
Tulane University1167
Con^iaUdatwnJi to nui in£i£dihk. dau^htei,, ^eehi.l
(]amiio pioudo^aou,. WhiJi.!iowuui£./a!ita,littU.QiiidtEa/nin^
0^ luhat liou. rruui tomedaii bicomi,, ^ knuu- now would find
liouiidjj hilpin^ ot/uii . l^ou, haue- atuuuit bun. io aaiins and
oompaMiijonati., <u)upUdutilJidiiui,cuiddUtiJninjatwn.. L^oiLhaui,
ajC£omf)li!>kuL luhat ii attainable, ba only a, ^ew-. <7 uulL nufii.
jjoi^it hoiu. ^fulpedgou. kain. hoiu- to lual/c. and tktn. gou,hdptd
mi. utalk, a^aui. LJou, aze,ma biight and thinJny !>tai,l
fllLnm bui,,
^om.
/o^ iha/'^ aVi^l-C^o/y^e. aj/ /('it^dS of oAstaCi/e.3 ujith
youI- usuaj style, and QtaCe. l^e. ic^ouj you cui//
i^e ari e><(Ze-//&tit physic-icxn., ancl are. vet-yptoud a-f
yoa . ijooJ ludk) 2)/-- Pande!
LoVe, Petty, Mo/y?, aid 3>ad
CoMtai^/al'ioriS Js/^nl-f&t arid Mor-QOM. A//
yoc^t /lard ujot^ /las ce.ttai/i/y pojJ o-f-f.
You uj'i/I ii>ot/i Ae coojnd&i-fu/ /?h/3idia/i3
/^&Ciau3& you are. Aoth iAjotide-tfu/^&op/e.
.
iOe.ite Very proud o-f you
.
A// out /oVe. Mo/y?, 2>acl and Brian.
168 1 Tulane University
Dearjejf,
We feel such pride and happiness for you. You kept smiling, believing in yourself and following that third grade dream of
becoming a doctor You are there! CONGRATULATIONS
We love you.
Mom and Dad
Seize the Moment
Seize the moment before its gone Ifor another day begins at dawn. I Embrace the )iight winch brings you rest I awake and know
you did your best. /Fight each fight and run each race-it matters not ifyou win or place. I Seize the moment you'll be blest
I then rest assured you passed the test, Ifor he who tries can never fail I when God directs the ship lue sail. I Seize the moment
and hold it dear / and rise by faith above yourfear
Dearest Beckv,
I'm 50 very proud of you and all you've accomplished! I'd be
remiss if 1 didn't take credit for a little moral support here
and there, but you're the one who did the studying, endured
ail the crappy residences and spent endless nights on call. Thetime I've spent with you has been the best three years of mylife. 1 can't wait to start the rest of our life, finally and really.
together, forever.
Congratulations, I love you with all my heart,
Don ^^^^^^^^^^^^^^^^
p^'-f wHT^^^^^l
^^pcnccr — \/i^UA ^rcdt -^riAe dnd X/DVi/
Tulane University1169
iJlllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllllb
"You've come a fona way, 6a6xjl We're
ver\jj)roudoj ifou, Jessical"
Love, ivlom ancf'Kim
/" =
S€>A^^'^^^' \
-riiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiir
'^ec/h'MU/.
^'0/:/iM. ti/ne. Sfa//> /'c/n//tc/ec/o/'l/iccfa/'ia//o//o/^///eAocm,
":y'ootsie/M'' ut/iere al tt/n.&s t/ia'e (ucrc cAaateo .s.te/>S' ana-
io/w/t c/ti£siianecl, ffod resAoru/ed (Aat (Aose a/e/'e fu/ies
iv/ien (oe^ c/anced.' ^lis-is a/ie o/'lAo<se Cime-s. c/i ac/di/:io/i to
^t/-i£ /4. l^S'O. y/oti /laae mac/c /ne />rouc///luou/' a/.///el-
ios, mime, acac/e/n/cs a/7z//'n eoc/y c/qy ///c' '2/ou tve/'e lAc/t.
nacv' anc/III///a/wrn/J!- 6e nw. /ia6u..
0ad
170| Tulane University
Congratulations to Dr.
Stacy Heimburger, my smart,
Deautiful and talented
daughter- a 2poo ana Icind
sister who overcame manu
obstacles to achieve this
reat success.
Love Mom, Aaam, and Kommel.
Co/iataici/cjiiiofiSi coe aye proud o-p you :
IaJ/net-&/e.t yout jPa^ih /^lay /ea<J, e/voy li-fe,
e><p/o)-e. and Jo your ouj^ t/ii^a.
l<)& /oVs. you, 2>r. Pi~eS£*it!
Mo^ and ^eeJ
Adaw (The Trophy Husband)
You have made we so proud.
From the moment that I met
you, I knew that my life would
never be the same. The courage
and endurance that you showed
during this journey is inspiring.
You are a strong, beautiful
loving, and brilliant man; and I
have never been happier to call
someone my own.
All of My Love,
Marylyn (The Pabe)
Tulane University 171
Fy^o^AA, the vem begLiA.iA,LiA,0 there
was, a dreci^vt
Yesterday is already a dream, and tomorrow is only a vision; but today,
well-lived, makes every yesterday a dream of happiness, and every
tomorrow a vision ofhope.
-from the Sanskrit
Congratulations Kelly!! Love, Mom, Dad, Uam, Scott & Rachael
Coi^gratu.LntioiA,£ Dr. Chad Abbott'.
I am. io ffou-d of you. aiMi uour m,cit\.M ciccokM,pUskim,ei«-t£ Iia, Life.
c^radnatlvK-Q from. Tulav^e hAtdlcal SolnooL Ls a big oiM'.
As n teeiA-dger, you. showed n grewt Love forpeopLe ai^d heLpLi^g
others. I was, thrlLLed wheiA- mdk. voLu.n,teerecl with m.e, coacM-
L^vg the s-peciciL oLMMA-pLts Trcicte team,. An.d, wu hoiA-ed youtr
dain,cl\^Q slelLLs at the AdnptLve VroQi-am, dcnA-tes. t+ow does the
'"RM-v^i/^ii/^Q MciiA.' go aQaivLl
Yon wi-LL hcix/e m,fiw,y i/nore Life eAperi.eiA,ces thcit l hope you. ltar\r^
from. niA,d treasure. I feiA-ow Losi.iA,g your father was tough, but
youfoLLowed uou.r drtam^to cittei^d m,edlcciLschooL. your father
wouLd have laeeiA- very proud ofiAou. tte's teeepi-i^-g ciia, eye oia, you
frokw. dloove.
you teki-ow I wLLL be there for wu everu step of the way.
Lovi/tgLy, your step-«<.om.,
Lisa Kadowatei
YoiA/ are/ going^ to- he^ cvyv e^ccepttoncib
doctor hecau4,e/ of- your convpcMMyOn/,
inteUlg^yncey, oYidy ev\thuH<Mnv! Yowcdwayy g^e^ your heart cvnd/ youh. We/
love/you/ cmd/ are/ yy- very proud/ ofyow!Way to go-, Vr. Wagner I
Love/,
Mama/, Vaddy, Anvuv, Verek/, Keith/, and/Morgarv
172 1 Tulane University
Jennifer,
Even as young as seven you had dreams. Through
your perseverance, hard work, gentle personality and
intelligence, you have earnedyour own cap...and a white
coat to go along with it We are so very proud ofyou. We
wish you happiness and we know you will be a competent
andcaringphysician. Tourpatients will loveyou almost as
much as we do.
Love,
Mom andDad
Team Family Practice
L-lfe Is R series, o-f begliA^iA^LiA-gs. Y^^^grfldu-fltloiA. frowL the Tulav^e s>c.V\ool o-f
MedlcliA^e Is iA.0 exceptloiA,. you. begliA,
fliA/Other phase of \AD\A.r Life, ci Life -filled
with prlvlLeges society ooiA/fers to oia^Lu
the very best, oia.Lm to those who have
eariA^ed. thei^. ALoiA^g with the privileges
co\^es a great bu-rdeiA, of respoiA^slblLlty.
We feiA^ow Mouc wlLL serve Mou.rpatleiA.ts
to the best of ujour ability; they wlLL
be fortu.iA.ate to have you. as their
physlclaiA.. we wlLL always be there to
su.pport Mou. liA, aiA,y way we c-aiA..
U)ve,
i>ad a\A.d iaov\a^
Tulane University1173
^^'si'^Jvw--'^*''*^' '
Jenica.,
I've 'nen/tr htut -vMxre fmid cfyim. thMt I oml today. Ynt
koA/t cicc&iAwU^keA mAAyck bivtymr Ire^t dam are yelr to
c&me. Take tmu to itoP omA um.M the ras^ aJxnw tke umy
(arUmMy). FaMuiy k vtry iMAMrtoMt to you and kjtyw
thai IwM always Ik there -for you. That's what duds are
for! I wi/sh. you a/s i^uickjoy 04 you haxn aU/en -me. ifyou
evtr aeir tired of praxiicUia mzdiclne, I Imow -where you
and I coK aet a. areat fiafter route. Lei- -mi leoA/e you with
one Piece of adidce that I'm. sure they -Kever unrered in
nted sckffol - viervtr fut salt ok a -wound.
CoKaratuiatiom!
Dad
Wecommend you
for your „ ,
accomplishments
and wish you
continued
success.
Anaheim MemorialMedical Center
Congratulations, Tulane University
Medical Sctiool Graduates!
For over 25 years, Bryan Corporation has
been devoted to providing health care
professionals W\\h unique, high quality
nnedical devices and innovative
pharnnaceuticals.
We look forward to working with you
in the future!
For more information, call 1 -800-343-771 1 or visit our website at www.bryancorp.com
BRYANCORPORATION
174 1 Tulane University
Benchmark Brands
Congratulates the
Tulane Class of 2007
uFootSmartSMARTER, BETTER PRODUCTS FOR LOWER BODY HEALTH
Benchmark Brands is the leading
U.S. direct response marketer of foot
and lower body health products.
Visit us at www.footsmart.com
C H A F F E M c C A L L
We apply enduring principles in
changing times
Broad knowledge. Deep understanding.
Effective representation
Managed Health Care Tax Law Hospital Liability Litigation
Antitrust Health Care Contracting General Litigation
Labor and Employment Law Medical Malpractice Law
New Orleans * Baton Rouge * Houstonwww.chaffe.com
Congratulations
Tulane Class of 2007!
We wish you the best!
•VeCisco is proudto Have servedthe
dermatoCogic communityfor o-ver 25 years
6y offering innovative products,
superior customer sendee and
a comprenfiensive new practice
start-up program.
uEst. rgSo
DELASCO
VISIT US AT WWW.OhLASCO.COM
At First Bank and Trust we understand
the importance of investing in the future. Wecongratulate you on investing in your
future as v/ell.
As a Financial institution invested in community vitality, First Bank and Trust
is ready to cultivate a strong partnership with you, servicing your
private banking and investment needs by grovs'ing your business, building
dream equity, and delivering service that is alv/ays personal. Congratulations
(o the gradijaling class of Tulane University Medical Center.
ik'.FIRST BANK
AND TRUST i
Business. Mado Personal. =
Oiiu lAi IJANKiNt; Pauimu oi nil NiAv Oui.iiANs Saints
POYDRAS 584.5900 METAIRIE RD. 586.2720 ALGIERS 586.2640 ELMWOOD 586.2700
KENNER 586.2600 MANHATTAN 586.2620 BATON ROUGE 225,925.3014
Tulane University1175
con^ratpitatlons, to tki
Forest Pharmaceuticals, Inc.Pharmaceuticals • Therapeutics • Healthcare • Ethicare • Managed Care • Specialty Sales
to the Tulane Class of 2007
Hitachi Medical Systems America recognizes the
important contributions made by Tulane graduates to
the advancement of health care and wishes you
the best of luck in furthering this
commitment to excellence.
HITACHIHITACHI MEDICAL SYSTEMS AMERICA. I
Slidell Memorial Hospital has the latest technology, a thriving com-
munity, and a staff dedicated to providing the best healthcare. Our
recent technology investments include a 64-slice CT scanner, an
Image-Guided Radiation Therapy (IGRT) system, three 4D ultrasound
systems, and digital mammography. ..v/ith more new equipment on
the way! Slidell is rapidly growing and so is our community hospital.
We can assist physicians in building an independent practice or join-
ing an established group. Come visit us and find out what
Slidell Memorial Hospital has to offer you.
Slidell Memorial Hospital
Your Hospitalfor Life!
PLEASE CONTACT PHYSICIAN SERVICES AT 985.649.8509
176 1 Tulane University
stryker'
Instruments
-^
Class of 2007
We Salute You
Congratulations
Graduates
Class of 2007r^W'^
Pamlab, LLC4-oC*MlMO)tAWNEM*L£ATE 7 Ij L'^ f \/
deplift^
f 4wiCUiaiM>UHINEMAL£ATE
Met^
• Panlor SS
CerefolinNAC l MGTHVLPOLFITer .
Graduating Class of 2007
Tulane University Medical School
CONGRATULATIONSon all you have accomplished and
all you hope to achieve in the future.
Watson® SM
SM
Tulane University1177
Congratulations Class of 2007
Tulane University Medical School Graduates
For over 20 years Alliance Imaging has provided turnkey solutions to hospitals and
other health providers for MRI, PET, PET/CT, CT and Radiation Oncology. Alliance
partners with hospitals and healthcare providers for Diagnostic Imaging Centers,
Shared Mobile Services, and Cancer Services with a focus on Radiation Therapy.
We look forward to working with you in the future!
/^F\
^ •_ i,"^ ' -«.
(^ AllianceImagingwww.allianceimaging.com 800.362.5816
4020 McEwen Rd, Ste 152. Dallas. TX 75244 Contact: Robert Hardy
When it comes to your career, you want to be part of an
experienced health care team that is driven to provide top
quality care. Forrest General and its staff strive to provide
the best possible care— from medical emergencies to
spinal or open-heart surgeries, from delivering babies to
managing diabetes or other chronic illnesses.
Forrest General Hospital is also home to the region's only
Level II Trauma Center— offering the highest level of
trauma care available in the area. If you're looking for a
place to make your home, join Forrest General. Working
together, we can achieve great things!
|)ForrestGeneralHOSPITAL
Call FGH OnCall at 7-800-844-4445 to find out more about Forrest General
and the opportunities available to you, or visit forrestgeneral.com.
Congratulations graduates
from your friends at
HEALTHPOINT ®
Advancing medicine thru products in
woundcare, dermatology and surgery.
HEALTBPOIBITA DFB COMPANY
®
178 1 Tulane University
Coventry Health Care Congratulates
the Tulane University Medical School
Class of2007!
TCOVE N TRYHealth Care of Louisiana. Inc.
Group and Individual Health Insurance Plans
Designed to Meet YOUR needs.
^ Direct access plan designs (specialist referrals not
required.)
Prescription Drug Coverage.
Preventative vision benefits & hardware discounts.
Dependent out-of-area coverage.
Emergency and urgent care coverage titroughout
the United States and Puerto Rico.
"^ WellBeing health and Wellness programs.
Y Excellent Customer Service,
For more information, visit us at CHCLA.COM.
Life has its moments.
Graduation is one you'll
remember forever.
Congratulations to
the Tulane University
Medical Center's
Class of 2007.
^ MARSH FIELD CI, I NIC,
CONGRATULATIONS
\\c take our licit of]
to the oniaiiatniii class
of liilanc L nivcrsity
1KlcJical Center.
And we welcome you
as a trusted partner
in providing quality
patient care.
^ ALLERCAIMINNOVATION AT WORK
©2001 Allcrgan, Inc., Ininc, (]A 92(112
\\'\v\\'.,illci;2an.coiii
Tulane University1179
Congratulations, Graduates
!
From Kindred HospitalNeiu Orleans
Kindred Hospital New Orleans is a long-term acute care hospital,
offering a full range of services for patients whose medically complex
conditions require the specialized care and prolonged recovery time
that conventional short-term acute care hospitals are not equipped to
provide. We are proud citizens ofNew Orleans and we congratulate
this year's graduates ofTulane University Medical School.
KindredTHospitalNew Orleans
3601 Coliseum Street
New Orleans, Louisiana 701 15
504.899.1555
504.894.7679 fax
www.kindredhospitalnola.com
Because it's always someone's
loved one on the table.
1
—
'
\%Every time a surgeon enters the operating theater,
a precious life is at hand. To ensure that the
instruments are ready when the surgical team is
ready to operate, healthcare facilities turn to IMS.
The IMS Milestone® process maximizes instrument
performance through:
• Education
• Proactive Maintenance*
• Trend analysis
• Process Improvement
• Surgical On-Site Support and Coaching
• Department Management
^^^^lLi>aVisit imsred.com or call 1 .800.783.9251 WimtfiMrfK
r ^
CONGRATULATIONS!Tulane University Medical School
Graduating Class of 2007
with 160 years of dedication to the advancement of
dermatology worldwide, Stiefel Laboratories, Inc. is proud
to join in the celebration of your success andfuture achievements!
Yesterday, Today, and Tomorrow
Stiefel Laboratories, Inc. Coral Gables, FL 33134 1 -888-STIEFEL (784-3335) www.stiefel.com
©2007, Stiefel Laboratories, Inc. All rights reserved- STI-18-2007-USA s STIEFEL
J180 1 Tulane University
CONGRATULATIONSTo the graduates ofTulane University
School ofMedicine
^
It is our privilege to help you
Redefine Recovery" with
significantly better post-op pain relief.
OnQpPainBuster'Redefining Recovery^
www.itio.com
interna ZentarisCommitted To Cure
We wishi to congratulate the
2007 graduating class of
Tulane University
Scinooi of IVledicine
/Eterna Zentaris is a specialist-driven biopiiarmaceuticai
company focused on endocrine thierapy and oncology.
www.aeternazentaris.com
Congratulations to the
Tulane Class of 2007Dedication to the highest standards of achievement helped
you reach your goals. At Karl Storz Endoscopy, we've
embraced that same ideal for more than 60 years.
Endoscopy is all we do. Our products prove advanced
design, precision craftmanship, and clinical effectiveness
will outlast shortsighted trends.
Quality is not disposable. Call us at (800) 421-0837.
STORZKarl Storz Endoscopy
Tulane University |181
As an adjunct to diet
CRESTOR is indicated as an adjunct to diet to reduce elevated levels of total-C,
LDL-C, ApoB, non-HDL-C, and TG, and to Increase HDL-C in patients with
primary hypercholesterolennia (heterozygous familial and nonfamilial) andmixed dyslipidemia
CRESTOR is contraindicated In patients with a known hypersensitivity to
any component of this product, in patients with active liver disease or
with unexplained persistent elevations of serum transaminases, In
women who are or may become pregnant, and in nursing mothers
It is recommended that liver function tests be performed before and at
12 weeks following both the initiation of therapy and any elevation of dose,
and periodically (eg, semiannually) thereafter. Should an Increase in ALT or
AST of >3 times ULN persist, reduction of dose or withdrawal of CRESTORIs recommended
The effect of CRESTOR on cardiovascular morbidity and mortality has notbeen determined; long-term outcome studies are currently underway
Please see Brief Summary of full Prescribing Information
on reverse side of this advertisement.
Please visit our Web site at www.crestor.com
• Rare cases of rhabdomyolysis with acute renal failure secondary to
myoglobinuria have been reported with CRESTOR and with other drugs In
this class. Patients should be advised to promptly report unexplainedmuscle pain, tenderness, or weakness, particularly if accompanied bymalaise or fever. Therapy with CRESTOR should be discontinued If markedlyelevated CK levels occur or myopathy Is diagnosed or suspected
• CRESTOR 40 mg is reserved only for those patients not achieving LDL-Cgoal at 20 mg. Patients initiating statin therapy or switching from anotherstatin should begin treatment with CRESTOR at the appropriate
starting dose
• Adverse reactions were usually mild and transient; the most frequent
adverse events thought to be related to CRESTOR were myalgia (3.3%),constipation (1.4%), asthenia (1.3%), abdominal pain (1.3%), andnausea (1.3%)'^
HELPS GET CHOLESTEROL RIGHT
loe CRESTOirrosuvastatin calcium
AstraZeneca^
182| Tulone University
BRIEF SUNWAARY: For lull Prescribing Inlormalion, see package insert.
INDICATIONS AND USAGE CRESTOR is mdicaleti: i. as an adjunct lo diet la
reduce e^evaled latal-C, LDL-C. Apo8. nonHDL-C. and TG levels and to increase HDL-C in
patients ftith prmary hyperctiolesleralemia [heterozygous familial and nonramilial) and
mixed dy^lipidemia (Frednckson Type lla and lib); 2. as an adjunct to diet for Ihe treatment
of patienis ft-ith elevated serum TG levels (Fredrickson Type IV): 3. to reduce LDL-C, lotal-C,
and ApoB jn patienis vviih tiomozygous lamilial hypercholesterolemia as an adjunct lo olher
lipid-lowering treatments (e.g., LDL aphersis} or if such treatments are unavailable
CONniAINDICAnONS CRESTOR is contraindicated m palients witfi a known hyper-
sensitivity to any component ot this product Rosuvastatin is contraindicated in palients
with active liver disease or with unexplained persistent elevallons of serum transaminases
(see WARNINGS. Lver Enzymes). Pregnancy and Lactation Alherosclerosis is a
dironic process and discontinuation ol iipid-lowenng dnigs during pregnancy should have
Bttle impact on Ihe outcome ol long-term therapy of primary hypercholesterolemia
Cholesterol and other producls of cholesterol biosynthesis are essenlial components for
fetal development (including synthesis ol sleroids and cell membranes). Since HMG-CoA
raiuclase inhibitors decrease choleslerol synthesis and possibly the synthesis ot other
biologically active substances derived from cholesterol, they may cause fetal harm when
^ministered lo pregnant women. Tfieretore, HMG-CoA reductase inhibitors are coniramdi-
cared during pregnancy and in nursing mothers. ROSUVASTATIN SHOULD BE ADMINIS-
TERED TO WOMEN OF CHILDBEARING AGE ONLY WHEN SUCH PATIENTS ARE HIGHLY
UNLIKaVTO CONCEIVE AND HAVE BEEN INFORMED OFTHE POTENTIAL HAZARDS, Itihe
palKnt becomes pregnant while taking Ihis drug, therapy should be discontmued immedi-
ately and Ihe patient appnsed oi the potential hazard to the lelus WARNINGS liver
Enzymes HMG-CoA reductase inhibitors, like some other lipid-lowering therapies, have
been associated with biochemical abnormalities of liver function The incidence qI persis-
tent elevations (>3 times Ihe upper limit ( normal [ULN] occurring on 2 or more consec-
utive occasions) in serum Iransaminases in lined dose studies was i. 0. 0, and 0.1 % in
patients wbo received rosuvastatin 5, 10, 20, and 40 mg, respecliveiy. In most cases, Ihe
elevations were transient and resolved or improved on continued therapy or after a brief
interruption in therapy Tiiere were two cases of jaundice, for which a relationship to rosuva-
sHIin Iherapy could not be determined, which resolved after discontinuation ol therapy
There were m cases ol \m lailure or irreversible liver disease in these tnals. H is recom-
mended hat liver function tests be performed before and at 12 weeks tollowing bo^ (tie
mitiab'on of therapy and any elevation ol dose, and periodically (e.g.. semiannually)
thereafter. Lr/er enryme changes generally occur in the first 3 monlhs ol treatment with
rasu'i'astatin Patients who develop increased transaminase levels should be monitored until
Ihe abnormalities have resolved. Should an increase m ALT or AST of >3 times ULN persist,
reduction of dose or wiina'av.-al ol rosuvastalm is recommended Rosuvaslatin should be
used w:th caution m pa'ienls who consume subslaniial quantilies of alcohol and/or have a
history of liver disease {see CLINICAL PHARMACOLOGY, Special Populaiions, Hepatic
Insufficiency). Active liver disease or unexplained persistent transaminase elevations are
contraindications to the use of rosirvastatin (see CONTRAINDICATIONS) Myopothy/RKabdomyolysis Rare cases ol rhabdomyolysis ivrth acute renal lailure secondary
to myoglobinuria have been reported nilh rosuvaslatin and with other drugs in this
class. Uncomp;:caieo myaigia has been reported m rosuvaslalin-lreaied patienis [see
ADVERSE REACTIONS). Creatine kinase (CK) elevations (>10times upper limit of normal)
occurred in 02% to Q,4% of patients taking rosuvastatin at doses up to 40 mg in clinical
studies. Treatment-related myopathy, defined as muscle aches or muscle weakness in
conjunclion vrth increases in CK values >10 times upper limit of normal, v/as reported m
up lo 0-1% ol patients taking rosuvastatin doses ol up lo 40 mg in clinical studies. In clin-
ical triafe, Ihe incidence ol myopathy and rliabdomyotysis increased at doses ol rosuva-
statin above ^e recommended dosage range (5 lo 40 mg). In postmar1(eting experience,
effects on skeletal muscle, e.g. uncomplicated myalgia, myopathy and, rarely, rhabdomy-
olysis have been reported m patients trealed wilh HMG-CoA reductase inhibitors including
rosuvastatin As wilh olher HMG-CoA reductase inhibitors, reports ol rhabdomyolysis wfih
rosiwastatin are rare, but higher at Ihe highest marketed dose (40 mg). Faclors that may
predispose patients lo myopatliy with HMG-CoA reductase inhibilors include advanced age
{>K years), hypolfiyroidism, and renal insufficiency. Conseouently: t. Rosuvastatin
should be prescribed with cautran in patients wilh predisposing factors for myopathy, such
as. renal impairment (see DOSAGE AND ADMINISTRATION), advanced age, and inade-
qualely treated frypotftyroidism Z Palients should be advised to promptly report unex-
pbined muscle pain, tenderness, or weakness, particularly if accompanied by malaise or
fwer, Rosirvastatin iberapy should be discontinued if markedly elevated CK levels occur or
myopathy is diagnosed or suspected. 3. The 40 mg dose of rosuvaslatin is reserved only for
those palients vrtio have not acfiieved Iheir LDL-C goal utilizing Ihe 20 mg dose of rosuva-
stalm once daity (see DOSAGE AND ADMINISTRATION). 4. The risk ol myopalhy during
Ireatment with rosuvaslatin mjy be increased vflth concurrent admimslralion ol olher lipid-
lo-ivering therapies or cydosporine, (see CLINICAL PHARMACOLOGY, Drug Interactions,
PRECAUTIOfJS, Drug Interactions, and DOSAGE AND ADMINISTRATION), The benefit of
brfier alterations in lipid levels by the combined use ol rostivastatin with fibrates or
niacin sliojid be carefully weighed against Ihe potential risks of this combination.
Combination tfierapy wilh rosuvastatjn and gemlibrozil should generally be avoided.
ISe« DOSAGE AND ADMINISTRATIOH and PflECAUTIONS, Drug Interactions). 5. Tlie risk
of myopathy ilurinfi treatment with rotuvastatin may be increased in circumslances
liitft increae roiuvajtatin drug levels (tee CLINICAL PHARMACOLOGY. Special
PopslalJon], Race and Renal Insufficiency, and PRECAUTIONS. General)
: Rosnislatin Itierapy should alto be temporarily withheld In any patient with an
aole, unois condition tuggeitne ol myopathy or predisposing b the development ol
renal faikve tetondary lo rhabdomyalysts (e.g.. sepsis, hypotension, dehydration,
mjir sniffy, trajma. severe melabolic. endocrine, and electrolyte disorders, or
tmatiM utzures) PRECAUTIONS Generol Be'ore \'\:mmq therapy with
raswasWin, an attempi 'MM be rr.aOe to control hypercholeslerolemia with appropriate
(M and atercse, wti^nl recuclm 'n obese patients, and ireatment ol underlying medical
proWemi _($« INDKATIOMS m USAGE). Admmistralion ol rosuvastatin 20 mg to
padents wWi iwere rena) impairmenl (0^ <30 mL/min/1.73 m^) resulted in a 3-foltl
increase ii pfasma cononlraliofis ol roswastiiin compared v/ilh healthy volunteers (see
WARNINGS, Myopathy/Rhabdomyolysisand DOSAGE AND ADMINISTRATION). The resull
Ola taiQe phamiacofcMieliC study conducts) in Ihe US demonstrated an approximate 2-loid
ctovaEiofl In median exposure in Asian tubieds (having either Filipino, Chinese. Japanese.
Korea/t, Vietnamese or Asiart-lndian origin} compared with a Caur^ian control group. This
inueau should be considered when making rosuvaslatin dosing decisions lor Asian
patienis. (See WARNIW^, Myopathy/Rhabdomyoiysis; CLINICAL PHARMACOLOGY
Special PopUatiOin, Rac«, and DOSAGE AMD ADMINISTRATIONlInformation for
Parienl>Raiefl(SthouldbeadviMdlorepor1(>rompl)yune):ptainedm/.<J-::i;i- - n.
iMse,or«eato>ess,parifcul3/lyllaccomi>anledbymalaii«orf?/er. V/huii/i'inr. >.
stMlriiiMh3n3taTiinurn2rKJmaone«umhydrnidecomt)frt;ton^ii'.>-.'; [ii".i't^<ri'h'.iri
telalW3llo$t2fiOOTaflerroj(MSUlmadmiriiflra!/;n(>,^',_'. '.^ 'h;--!/;-' ,,/
Drvo H«actiom) laboratory Jtttt in the tc,i;/s:'^l' :I'k^i I'i ,\ '.(.mi
(fpMicfcDDMi/e proieruria and rnvjoKopic nemaiuria were otn«''r-] '((i'.(«, -,
tttMiett6 vdtatt, predominant^/ in p3i«fits dcrKd above the '': "hm> i.: <r
afigeftt,WnHi)-Hoi(iwef,ttoriidi*iaw5imo(elfe<]uerrinp?i<^f[' unw./.iwt.uui
40iiig,wlMconiparedtolowefdOKiolr(>wvastiIinorc^ym[. ^'.r t::ii i -..jnttv^as
generjly tiani«« andw not SMOceUd wilh wortenirj r-:^^ '.ww.u ^iirMjgFi the
cMcaliigfliftanctdthafndinoisiKilcrwwn.adosered/.''.' '.ti'^u': v '.w.&Mfor paiM on roiwaititin 40 mg Ihe^ wfth umtiUw-.i '/'.\-<-\ p'-'cnr.^
10 ii0ii»coatfaMHlef(diiillhGyct«porfne in cardiac tr:.f >w.i 'in
MeaHCnaMfmeanWCverelflerssedll-foldandM'.' < i v i<
lKa%^m«f).ThHeitwea$es are cornideted lobe'. 'i ' m ii^I'mj-^
fpecol comiMfafion ii the doting ot rojwattabn lo ini^ii:. ^hn(i mu>mm\
cyclosporine (see WARNINGS, Myopalhy/Rhabdomyolysis, and DOSAGE AND ADMINIS-
TRATION) Warfarin: Coadministration of rosuvastatin to palients on stable warfarin
therapy resulted in clinically significant rises in INR (>4, baseline 2-3). In patients taking
coumarin arlicoagulants and rosuvaslatin concomitantly, INR should be determined before
starting rosuvastatin and Ireguently enough during eariy Iherapy to ensure thai no signili-
cant alteralion of INR occurs. Once a stable INR time has been documented, INR can be
monrtored at the intervals usually recommended lor patienis on coumarin anticoagulants. II
Ihe dose of rosuvaslatin is changed, the same procedure should be repeated. Rosuvaslatin
Iherapy has not been associated with bleeding or with changes in INR in patients not laking
anticoagulants. Gemfibmzil: Coadministration of a single rosuvastatin dose to heahhy
volunteers on gemlibrozil (600 mg twice daily) resulted m a 2.2- and 1 .9-lold, respecliveiy,
increase in mean Cmax and mean AUC ol rosuvastatin [see DOSAGE AND ADMINISTRA-
TION). Endocrine Function Although clinical studies have shown that rosuvastatin
alone does not reduce basal plasma Cortisol concentration or impair adrenal reserve,
caution should be exercised if any HMG-CoA reductase inhibitor or other agent used to
lower choleslerol levels is administered concomilanlly v/ith drugs thai may decrease the
levels or activity of endogenous steroid hormones such as keloconazole, spironolactone,
and cimelidine. CNS Toxicily CNS vascular lesions, characterized by perivascular
hemorrhages, edema, and mononuclear cell infiltration of perivascular spaces, have been
observed in dogs treated with several other members of this drug class A chemically
similar drug in this class produced dose-dependent optic nerve degeneration (Wallenan
degeneration of relinogeniculate libers) in dogs, at a dose that produced plasma drug levels
about 30 times higher Ihan the mean drug level in humans taking Ihe highest recommended
dose. Edema, hemorrhage, and partial necrosis in the inlerslitium of Itie choroid plexus was
observed in a female dog sacrificed moribund at day 2'1 al 90 mg/kg/day by oral gavage
(systemic exposures 100 times the human exposure at -lO mg/day based on AUC compar-
isons) Corneal opacity was seen in dogs trealed lor 52 weeks at 6 mg/kg/day By oral
gavage (syslemic exposures 20 limes the human exposure al 40 mg/day based on AUC
comparisons). Cataracts were seen in dogs trealed for 12 weeks by oral gavage at
30 mg/kg/day (systemic exposures 60 limes Ihe human exposure at 40 mg/day based on
AUC comparisons). Retinal dysplasia and retinal loss were seen in dogs treated for <! weeks
SOSCRESTOR^rosuvastatin calcium
by oral gavage al 90 mg/kg/day (syslemic exposures 100 limes the human exposure at
40 mg/day based on AUC) Doses <30 mg/kg/day (systemic exposures <60 limes the
human exposure al 'lO mg/day based on AUC comparisons) following Ireatmem up lo one
year, did not reveal retinal Imdings Carcinogenesis, Mutagenesis, Impairment
of Ferriiily In a 104-v/eek carcinogenicity study in rals a! dose levels ol 2. 20, 60, or
80 mg/kg/day by oral gavage, Ihe incidence of uterine stromal polyps ms signilicanlly
increased in females at 80 mg/kg/day at systemic exposure 20 limes the human exposure
at 40 mg/day based on AUC. Increased incidence of polyps was not seen al lower doses. In
a 107-v/eek carcinogenicity study in mice given f 0, 60, 200 mg/kg/day by oral gavage, an
increased incidence ol hepatocellular adenoma/carcinoma was observed al 200 mg/kg/day
al syslemic exposures 20 times human exposure al 40 mg/day based on AUC. An increased
incidence of hepatocellular tumors was not seen al lower doses. Rosuvastatin was not
mutagenic or clastogenic with or without melabolic activation in the Ames test with
Salmonelis typhimurium and Escherichia coli, the mouse lymphoma assay, and the chro-
mosomal aberralion assay m Chinese hamsler lung cells Rosuvaslatin was negative in the
in vivo mouse micronucleus lest In rat fertility studies with oral gavage doses of 5, 15,
50 mg/kg/day, males were treated lor 9 weeks prior lo and throughout malmg and lemales
were trealed 2 weeks prior to mating and throughout mating until geslalion day 7. No
advene effect on fertility was observed at 50 mg/kfi/day (syslemic exposures up lo 1 times
human exposure at 40 mg/day based on AUC compansons). In testicles ol dogs treated
with rosuvastatin at 30 mg/kg/day lor one momh, spermatidic giant cells were seen.
Spermalidic giant cells were observed in monkeys afler 6-monlh Ireatment al 30 mgAg/day
in addition to vacuolation of seminiferous tubular epithelium. Exposures in the dog were 20
times and in the monkey fO times human exposure al 40 mg/day based on body surface
area comparisons. Similar findings have been seen with other drugs in this class.
Pregnancy Pregnancy CalsgoryXSee CONTRAINDICATIONS. Rosuvaslatin may cause
felal harm when adminislered lo a pregnant woman. Rosuvastalm is conlraindicaled in
women wtio are or may become pregnant. Safety in pregnant women has not been eslab-
lished. There are no adequate and v/eil-controlled studies of rosuvastatin in pregnant
women. Rosuvastatin crosses the placenta and is found in fetal tissue and amniotic lluid at
3% and 20%, respectively, ol Ihe maternal plasma concentration lollowmg a single
25 mg/kg oral gavage dose on gestation day 16 in rats. A higher lelal lissue dislnbulion
(25% maternal plasma concentration) v/as observed in rabMs aHer a singfe oral gavage
dose of 1 mgAg on gestation day !8. If this drug is adminislered to a woman wilh repro-
ductive potential, the palient should be apprised of the polemial hazard lo a fetus. In female
rats given oral gavage doses of 5. 15. 50 mg/kg/day rosuvastatin before mating and contin-
uing through day 7 postcoilus results in decreased fetal body weight (female pups) and
delayed ossilicalion al the high dose (syslemic exposures 10 times human exposure at
40 mg/day based on AUC comparisons), in pregnant rats given oral gavage doses of 2, 20.
50 mg/kg/day Irom geslatlon day 7 through lactation day 21 (weaning), decreased pup
survival occurred in groups given 50 mg/kg/day, systemic exposures >12 limes human
exposure at 40 mg/day based on body surface area comparisons. In pregnant rabbits given
oral gavage doses ol 0.3, 1 , 3 mgAg/day Irom gestalion day 6 lo laclalion day 18 (weaning),
exposures equivalent lo human exposure at 40 mg/day based on body surface area compar-
isons, decreased fetal viability and maternal mortality was observed. Rosuvaslatin was not
leratogenic in rals at £25 mg/kg/day or in rabbits <3 mg/kg/day (syslemic exposures
equivaleni to human exposure at 40 mg/day based on AUC or body surlace comparison,
respecliveiy). Nursing Mothers It is not known whether rosuvaslatin is excreted in
human milk Studies in laciaimg rals have demonslraled that rosuvastatin is secreted into
1.' :! '(ilk at levels 3 times higher than thai obtained in Ihe plasma following oral gavage
''IBecause many drugs are excreted in human milk and because of the potential lor
Hi'.ir, adverse reactions in nursing inlants Irom rosuvastatin, a decision should be made
v/hether lo discontinue nursing or admimslralion ol rosuvastarn laking mlo accoum the
importance ol ihe drug lo Ihe ladalmg woman Pediatric Use The safely and elleclive-
noss in pediatric patienis have nol been established Treatment experience wHh losuvaslalin
in a pediatric populalion is limited to 8 palients with homozygous FH. None ol those patients
was below 8 years ol age. Geriatric Use Of the 10.275 paliems in clinical studies with
rosuvaslalin. 3.159 (31%) were 65 years and older, and 698 (6 8%) were 75 years and
older The overall Irequency of adverse evems and types ol adverse events were similar in
palients above and below 65 years ol age. (See WARNINGS, Myopathy/Rhabdomyolysis
)
The efficacy ol rosiwasiatin In tlio geriatric population !^-G5 r^r. ol ;ion) was comparable
10 the ellicacy observed in tho non-elderly ADVERSE REACTIONS Rosuvaslatin Is
oenerall/ well tolerated Adverse readions have usu;;!!; mm: Luiniiansienl Inclmical
'ii'ii- . 'i\ 10.275 patienis, 3.7% were discontinued due lo adverr,(; expriiiences allnbulable
i'> r.'M/A'Min. The most Irequent adverse events thought lo be relaled lo rosuvastatin
•"": :v/;i|Qla, constipalion, asthenia, abdominal pain, and nausea. Clinical Adverse
Exporiencet Adverse experiences, regardieGS of causalily assessmonl, rcponod In ^2%
of palients m placebo-corlrolled clinical studies of rosuvaslatin are shown in Table 1;
discontinualions due lo adverse events in these studies ol up to 12 weeks duralion occurred
in 3% of palients on rosuvastatin and 5% on placebo.
Table 1. Adverse Events in Placebo-Conlrolled Studies
Rosirvaslalin Placebo
Adverse eveni N=744 N=382
Pharyngitis 9.0 7,6
Headaclie 5.5 5,0
Diarrtiea 3,1 2,9
Dyspepsia 3,4 3,1
Nausea 3,4 3.1
Myalgia 2,8 1,3
Asthena 2,7 2.6
Back pain 2,6 2.4
Flu syndrome 2,3 1,8
Urinary Iracl inlection 2,3 1.6
Rhinitis 2,2 2,1
SinusMs 20 1,8
In addition. Ihe following adverse events were reported, regardless of causality assessment.
in >1% of 10,275 patients trealed wilh rosuvastatin in clinical studies. The evenis in
Italics occurred in >2% ol these patients Body as a Whole: AbiJominal pain,
accidental injury, chest pain, inlecHon. pain, pelvic pain, and neck pain. Cardiovascular
System: Hypertension, angina pectoris, vasodilalalion, and palpitation. Digestive
System: Constipation, gastroenteritis, vomiting, llatufence. periodontal abscess, and
gastritis. Endocrine: Diabetes mellilus. Hemic and Lymphatic System: Anemia and ecchy-
mosis Metabolic and Nulrilional Disorders: Peripheral edema. Musculoskeletal
System: Arthritis arthralgia, and pathological Iraclure Nervous System: Dismess,
insomnia hypertonia, paresthesia, depression, anxiely, vertigo, and neuralgia Respiratory
System: Bronchitis, cough increased dyspnea, pneumonia, and asthma. Skin and
Appendages: RsshM pruritus. Laboratory Abnormalities: In Ihe rosuvastatin clinical trial
program, dipstick-posilive proteinuria and microscopic hematuna were observed among
rosuvastalin-trealed patienis, predammanlly in palients dosed above the recommended
dose range (i.e., 80 mg) However, this linding v/as more Irequent in palients taking rosuva-
statin 40 mg, when compared to lower doses of rosuvastatin or comparator statins, though
ft was generally transient and was not associated wilh worsening renal function. (See
PRECAUTIONS, Laboratory Tests) Other abnormal laboratory values reported were
elevated crealinine phosphokmase, transaminases, hyperglycemia, glutamyl transpepli-
dase, alkaline phosphatase, bilirubin, and Ihyroid lunction abnormalities Other adverse
events reported less frequently than 1% in the rosuvastatin clinical study program, regard-
less of causality assessment, included arrhythmia, hepatitis, hypersensitivity reactions
(i.e., lace edema, thrombocytopenia, leukopenia, vesiculobullous rash, urticaria, and
angioedema). kidney lailure, syncope, myaslhema, myositis, pancrealitis, photosensitvify
reaclion, myopathy, and rhabdomyolysis. Postmarketing Experience In addition lo
the evenis reported above, as with olher drugs in this class, tlie following event has been
reported during post-marketing experience with CRESTOR, regardless ol causality assess-
ment: very rare cases of laundice. OVERDOSAGE There is no specilic Ireatment in the
event of overdose. In the event ol overdose, the patient should be heated symplomaticaliy
and supportive measures inslituted as required Hemodialysis does nol signilicanlly
enhance clearance ol rosuvastalm. DOSAGE AND ADMINISTRATION The patiem
should be placed on a standard cholesterol-lowering diet belore receiving CRESTOR
and should continue on Ihis diet during treatment, CRESTOR can be adminislered as
a single dose at any lime of day. wilh of without food. Hypercholesterolemia
(Heterozygous Familial and Nonfomilial) and Mixed Dyslipidemto
[Fredrickson Type lla and lib) The dose range tor CRESTOR is 5 to 40 mg once
daily. Therapy with CRESTOR should be individualized according to goal ol therapy and
response. The usual recommended starting dose ol CRESTOR is 10 mg once daily.
However, inilialion of therapy with 5 mg once daily should he considered (or patients
requiring less aggressive LDL-C reductions, who have predisposing laclors lor myopathy,
and as noled below lor special populations such as patienis laking cyclosporine, Asian
palients, and patienis wilh severe renal msulliciency (see CLINICAL PHARMACOLOGY,
Race, and Renal Insufficiency, and Drug Inferactions. For patienis with marked hypercho-
lesterolemia (LDL-C > 1 90 nig/dl) and aggressive lipid targets, a 20-mg starting dose may
be considered. After initiation and/or upon titration of CRESTOR, lipid levels should be
analysed wilhin 2 to 4 weeks and dosage adjusted accordingly The 40-mg dose ol
CRESTOR is reserved only lor those patients who have nol achieved their LDL-C goal
utilizing the 20 mg doss ol CRESTOR once daily (see WARNINGS, Myopathy/
Rhabdamyolysis). liVhen initiating statin therapy or switching Irom another statin
therapy, the appropriate CRESTOR starting doss sfiould lirst be utilized, and only then
titrated according lo the patient's individualized goal ot therapy. Homo^gousFamilial Hypercholesterolemia The recommended starting dose ol CRESTOR is
20 mg once daily in palienis wilh homo^gous FH The maximum recommended daily dose
is 40 mg. CRESTOR should be used in these palients as an adjunct to olher lipid-lowering
treatments (e.g., LDL apheresis) or if such treatments are unavailable. Response lo therapy
should be estimated Irom pre-apheresis LDL-C levels Dosage in Asian Patients
Inilialion ol CRESTOR therapy wilh 5 mg once daily should be considered lor Asian
palients The potential lor increased syslemic exposures relative lo Caucasians is relevant
v/hen considering escalation ol dose in cases where hypercholeslerofemia is not adequately
controlled at doses ol 5, 10, or 20 mg once daily. (See WARNINGS, Myopathy/
Rhabdomyolysis. CLINICAL PHARMACOLOGY, Special Populaiions, Race, and PRECAU-
TIOMS, General) Dosage In Patients Taking Cyclosporine In patienis laking
cyclosporine, Iherapy should be limited to CRESTOR 5 mg once daily (see WARNINGS,
Myopalhy/Rhabdomyolysis, and PRECAUTIONS, Drug Interactions). Concomitant
Upid-Lowering Therapy The effcci of CRESTOR on LDL-C and tolal-C may be
enhanced v/hen used in combination wilh a bile acid binding resin. If CRESTOR is used in
combination wilh gemfibrozil, the dose ol CRESTOR should be limiled lo 10 mg once daily
(see WARNINGS, Myopalhy/Rhabdomyolysis, and PRECAUTIONS, Drug Inleraclions).
Dosage in Patients With Renal Insufficiency No modilication ol dosage is
necessary lor palients wilh mild to moderate renal insufliciency. For palienis with severe
renal impairment {Ql^, <30 mLymln/1.73 m^) not on hemodialysis, dosing ol CRESTOR
should be started al 5 mg once daily and nol lo exceed 10 mg once daily (see
PRECAUTIONS, General, and CLINICAL PHARMACOLOGY, Special Populations, Renal
Insufliciency).
Rjt only
flelerenees: 1. Prescribing Inlormalion for CRESTOR, AslraZeneca Pharmaceuticals LR
Wilmington, DE. 2. Data on file, DA-CRS-OI
CRESTOR is a registered trademark of the AslraZonoca group ol companfes
Pleaso visil our Web site at www.creslorcom
©AslraZonoca 2007 Licensed from SHIONOGI & CO,, LTD., Osaka. Japan
Manulaciured lor AslraZeneca Phaimaceulicals LP Wilminglon.DE 19850
By IPR Pharmaceuticals, Inc. Carolina, PR 00984
PCC 630101 30043-00
Rev 08/05 247665
AstraZeneca ir
Tulane University1183
SPONSORED BY
Salix#.Pharmaceuticals, Inc.
Advancing Treatment in Gastroenterology™
MAKERS OF
l^loviPrep CbsmolOVII(PEG-3350, Soim Sulfate, Sodium Chloride, Potassium Ctiloride,
Sodium Ascorbate and Ascorbic Acid for Oral Soioo)
.USP
and sodium ptiosphate dibasic aotiydraus, USP) Tablets
COLAZAl^ Xifaxan©balsalazide disodm (rifaximin) tablets 200 mg
www.Salix.com
184| Tulane University
We Impact Life
at Every Stage
At Abbott, we deliver
products you can count
on to provide superior
patient care — across
the spectrum of health.
Vascular
Diabetes Care
Metabolics
Spine
IVIolecular
Pain Care
Renal Care
Immunology
Anesthesia
Discovering new and better ways
to manage liealth has driven our
work for more than a century. Today,
our comprehensive line of products
spans the continuum of care -
from pharmaceutical therapies and
nutritional products to diagnostics
and surgical devices - addressing
important health needs from infancy
to the golden years, and in more
ways than even
We strive to earn your continued
trust by delivering high-quality, reliable
products backed by leading-edge
science and expertise across a range
of health care specialties. We deliver
on our promises by focusing on what
matters most: innovative care and
a desire to make a meaningful
difference in all that we do.
Visit us at abbott.com
Anti-lnfectives
Neuroscience
Virology
a
Cardiovascular
Nutrition
Oncology
AbbottA Promise for Life
Tulatie University |185
The Perfect Combination
4M^
^'e^
CURREiVT OPPORTUNITIES:
FamiK Practice
Internal Medicine
General Surgery
Neurosurger}'
Urology
Interventional Cardiology
ditional values. High-tech medicine. You'll find them
both in Springfield, Ohio. You can choose a suburban or
rural lilestyle, just right for your family. And just a short
drive from Colimibus and Dayton.
At Conmiunity Mercy Health Partners, health care is
state-of-the-art . . . deUvered with compa-ssion. Part of one
of the nation's largest not-for-profit health systems, we
offer cardiac surgery, cancer care in our regional cancer
center, obstetrics, pediatrics, and state-of-the-art diagnostic
services.
We offer rewarding practice opportimities. where you
can put your values and your skills to work.
Send CV or call David Andrick,
Director of Physician Recruitment, 937-328-8037
Community Mercy Health Partners
1 South Limestone St.
Suite 600
P.O. Box 688
Springfield, OH 4,5501
E-mail: [email protected]
^\g^
% CommunityMercyHealth Partners
186 1 Tulane University
CLEAN
t.OFMETAIRIE.J
MEAN
ATTENTION:
OF METAIRIE
885-3000 ' 3100 LIMT. STREETWWW.CADII.UCOFMKTAIRIR.COM
Family Practice and
Internal Medicine ResiderTEs
Exciting opportunities for
Primary Care Physicians:
In an effort to meet the healthcare needs of the
metropolitan New Orleans area, EJGH is expanding
its network of primary care physicians as the
community continues to rebuild.
This is an opportunity to be involved in the evolution
of healthcare delivery as the region continues to
re-establish its healthcare infrastructure.
Emailyour resume to
:
EastJefferson General Hospital
BEYOTND THE CUTTIMQ EDGf..
WWW.EJGH.org
Tulane University |187
Quest DiagnosticsNationally Recognized,
Locally Committed'
As the nation's leading provider of diagnostic testing, information and services. QuestDiagnostics offers the broadest range of innovative diagnostic services to meet the needsof you and your doctor.
So, when your doctor wants you to have a health related test, count on QuestDiagnostics. With patient service centers in Mississippi, Louisiana and Texas, finding alocation convenient to you will never be a problem.
For more information on our services, speak to your physician or visit us atwww.questdiagnostics.com .
Quest, Quest Diagnostics, the associated logo and all
associated Quest Diagnostics marks are the
trademarks of Quest Diagnostics. © 2004 Quest Diagnostics
Incorporated. All rights reserved.
(4W^ QuestDiasrnostics^ ®
Dialysis
Drug Delivery
Infusion Systems
Interventional
Irrigation/Urology
IV Sets Et Access Devices
Needlefree IV Systems
Nutrition ft Solutions
Pain Control
Pharmacy Admixture
Products £t Services
Vascular Access
Sharing Expertise.™
It's more than a philosophy.
It's a promise.
Sharing Expertise includes listening to the wisdom of
colleagues, customers, and clinicians, it's more than a
philosophy. It's our promise to the healthcare community
and ourselves to continuously seek knowledge.
To expand it. To apply it. To share it.
All to help improve and save lives.
This is Sharing Expertise.
This is B. Braun.
BIBRAUNSHARING EXPERTISE www.bbraunusa.com
Rx Only. a2006 B. Braun Medical Inc., Bethlehem PA. All rights reserved, UofFL 307 JH
188| Tulane UnivL^rsity
LEADING THE QUEST FOR HEALTH.More than 100 years ago, Cedars-Sinai was a small
hospital whose goal was to provide the finest quality
care to the Los Angeles community.
Today our reputation for excellence extends around
the globe. Our commitment to medical research and
innovation, combined with our passion for patient
care, has made us one of the most dynamic and
highly renowned medical centers in the world.
Medical education has been a core mission of
Cedars-Sinai since its inception. Our residency and
fellowship programs enable physicians to develop
their clinical expertise as well as participate in a wide
range of research activities.
At Cedars-Sinai, there are more than 600 research
projects underway, and we're making new discoveries
and putting them into practice every day.
Our goal is to stay at the forefront of medical
advancement. Only in this way can we maintain the
gold standard of excellence in healthcare for another
century to come.
FIND OUT MORE ABOUT OUR GRADUATE MEDICAL EDUCATIONWWW.CEDARS-SINAI.EDU/GME
Cedars-Sinai.
Tulane University1189
<(Roche>
We all dream ofdoing big things.
Solving importantproblems.
Making a difference. Improving lives.
Transforming these dreams
into reality requires ambition,
creativity, and a company like ours to
help put all the elements together.
We Innovate Healthcare
From Research
to Real Life
Roche is a leader in preventing, diagnosing and treating
disease, enhancing the quality of life for everyone.
We invest almost $5 billion a year in innovative research,
and our capabilities combine traditional biomedical
science with the latest advances in biotechnology,
genetics and genomics. Our investment in research has
led to the introductions of important new medicines for
osteoporosis and flu. And our current pipeline includes
potential advances for treating cancer, diabetes, arthritis
and hepatitis C.
Few companies possess the global strength in both
diagnostics and therapeutics that Roche enjoys.
By forging closer linl<s between diagnosis and
treatment, we're leading the way to a new dimension
in healthcare-individualized medicine. This approach
identifies the best treatment for a specific
individual.
And since we understand that every
individual is unique, we strive to ensure
a diverse workplace. Roche encourages
creativity and embraces differences in talent,
education, work style, lifestyle and culture.
Arthritis, cancer, diabetes, hepatitis, HIV/
AIDS, influenza, nervous system disorders
and osteoporosis - just some of the real life
issues Roche is focusing on and providing
solutions for.
Visit our global Web site atwww.roche.com
or our U.S. Web site at www.rocheusa.com.
190| Tulane University
Pediatrix Medical Group, the nation's largest physician group practice of maternal-fetal, newborn
and pediatric subspecialists, congratulates Tulane University Medical School's Class of 2007.
1 ediatrix offers physicians the best of both worlds: the chnical autonomy and atmosphere of a local private
practice coupled with the opportunities, administrative relief and clinical support that come from an affiliation with
a nationwide network. The company is unique not only because of its clinical and business expertise, but because
it has made a major commitment to education. Through our Professional Development Award program we have
extended that commitment to the support of neonatal, pediatric cardiology, pediatric critical care and maternal-
fetal medicine fellows. The program, which provides recipients up to $25,000 annually, allows interested and
qualified individuals to pursue these fellowship programs while relieving some financial burden.
For more information, visit www.pediatrix.com.
P€DIRTRi:i:. OBSTETRIC.MEDICAL GROUP MEDICAL GROUP
1301 Concord Terrace, Sunrise, Florida 33323 Tel: 800.243.3839 www.pediatrix.com
Tulane University1191
Notes
192| Tulane university
Tulane University
Rudolph Matas Medical Library
1430 Tulane Avenue (SL-86)
New Orleans, LA 70112-2699
DEMCO
11 llllllllllllll
OCT 2 1 2008